Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dovitinib in recurrent or progressive glioblastoma
NCT01753713Phase 2Completed
- Sponsor
- Manmeet Ahluwalia
- Start
- Dec 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dovitinib in glioblastoma (GBM), sponsored by Manmeet Ahluwalia. Started Dec 2012; status: completed.
02
Drugs
dovitinib
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01753713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01753713.